nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—SLCO1B1—Dextrothyroxine—hypothyroidism	0.126	0.159	CbGbCtD
Sumatriptan—SLCO1A2—Liothyronine—hypothyroidism	0.101	0.128	CbGbCtD
Sumatriptan—SLCO1A2—Levothyroxine—hypothyroidism	0.101	0.128	CbGbCtD
Sumatriptan—SLCO1A2—Liotrix—hypothyroidism	0.0986	0.125	CbGbCtD
Sumatriptan—SLCO1B1—Liothyronine—hypothyroidism	0.0953	0.12	CbGbCtD
Sumatriptan—SLCO1B1—Levothyroxine—hypothyroidism	0.0953	0.12	CbGbCtD
Sumatriptan—SLCO1B1—Liotrix—hypothyroidism	0.093	0.118	CbGbCtD
Sumatriptan—ABCB1—Levothyroxine—hypothyroidism	0.0273	0.0345	CbGbCtD
Sumatriptan—ABCB1—Liothyronine—hypothyroidism	0.0273	0.0345	CbGbCtD
Sumatriptan—ABCB1—Liotrix—hypothyroidism	0.0267	0.0337	CbGbCtD
Sumatriptan—Heat intolerance—Levothyroxine—hypothyroidism	0.0115	0.0673	CcSEcCtD
Sumatriptan—Heat intolerance—Dextrothyroxine—hypothyroidism	0.0115	0.0673	CcSEcCtD
Sumatriptan—Temperature intolerance—Dextrothyroxine—hypothyroidism	0.00876	0.0514	CcSEcCtD
Sumatriptan—Temperature intolerance—Levothyroxine—hypothyroidism	0.00876	0.0514	CcSEcCtD
Sumatriptan—Heat intolerance—Liotrix—hypothyroidism	0.00843	0.0495	CcSEcCtD
Sumatriptan—Temperature intolerance—Liotrix—hypothyroidism	0.00644	0.0378	CcSEcCtD
Sumatriptan—Retching—Dextrothyroxine—hypothyroidism	0.00421	0.0247	CcSEcCtD
Sumatriptan—Retching—Levothyroxine—hypothyroidism	0.00421	0.0247	CcSEcCtD
Sumatriptan—Warmth—Liotrix—hypothyroidism	0.00332	0.0195	CcSEcCtD
Sumatriptan—Tetany—Liotrix—hypothyroidism	0.00324	0.0191	CcSEcCtD
Sumatriptan—Retching—Liotrix—hypothyroidism	0.00309	0.0182	CcSEcCtD
Sumatriptan—Muscle twitching—Liothyronine—hypothyroidism	0.00298	0.0175	CcSEcCtD
Sumatriptan—HTR3A—nerve—hypothyroidism	0.0029	0.105	CbGeAlD
Sumatriptan—Phlebitis—Liothyronine—hypothyroidism	0.00247	0.0145	CcSEcCtD
Sumatriptan—Swelling face—Liotrix—hypothyroidism	0.00222	0.013	CcSEcCtD
Sumatriptan—Venous thrombosis—Liotrix—hypothyroidism	0.00196	0.0115	CcSEcCtD
Sumatriptan—MAOA—nerve—hypothyroidism	0.00179	0.0652	CbGeAlD
Sumatriptan—Angina pectoris—Liothyronine—hypothyroidism	0.00179	0.0105	CcSEcCtD
Sumatriptan—DRD2—nerve—hypothyroidism	0.00177	0.0645	CbGeAlD
Sumatriptan—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00161	0.00948	CcSEcCtD
Sumatriptan—Myocardial infarction—Liothyronine—hypothyroidism	0.0016	0.00943	CcSEcCtD
Sumatriptan—Intestinal obstruction—Liotrix—hypothyroidism	0.00155	0.00911	CcSEcCtD
Sumatriptan—Cyanosis—Liotrix—hypothyroidism	0.00149	0.00878	CcSEcCtD
Sumatriptan—Feeling hot—Liotrix—hypothyroidism	0.00135	0.00791	CcSEcCtD
Sumatriptan—Tingling sensation—Liotrix—hypothyroidism	0.00132	0.00773	CcSEcCtD
Sumatriptan—Arrhythmia—Liothyronine—hypothyroidism	0.00131	0.00771	CcSEcCtD
Sumatriptan—Tenderness—Liotrix—hypothyroidism	0.00121	0.00712	CcSEcCtD
Sumatriptan—Hypertension—Liothyronine—hypothyroidism	0.0011	0.00649	CcSEcCtD
Sumatriptan—Muscle twitching—Liotrix—hypothyroidism	0.00108	0.00633	CcSEcCtD
Sumatriptan—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00107	0.00628	CcSEcCtD
Sumatriptan—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00107	0.00628	CcSEcCtD
Sumatriptan—Tachycardia—Liothyronine—hypothyroidism	0.00102	0.00599	CcSEcCtD
Sumatriptan—Fluid retention—Liotrix—hypothyroidism	0.001	0.0059	CcSEcCtD
Sumatriptan—Hypotension—Liothyronine—hypothyroidism	0.000976	0.00573	CcSEcCtD
Sumatriptan—Dehydration—Levothyroxine—hypothyroidism	0.00097	0.0057	CcSEcCtD
Sumatriptan—Dehydration—Dextrothyroxine—hypothyroidism	0.00097	0.0057	CcSEcCtD
Sumatriptan—Lightheadedness—Liotrix—hypothyroidism	0.000946	0.00556	CcSEcCtD
Sumatriptan—Dysphagia—Dextrothyroxine—hypothyroidism	0.000902	0.0053	CcSEcCtD
Sumatriptan—Dysphagia—Levothyroxine—hypothyroidism	0.000902	0.0053	CcSEcCtD
Sumatriptan—Phlebitis—Liotrix—hypothyroidism	0.000891	0.00523	CcSEcCtD
Sumatriptan—Angina pectoris—Levothyroxine—hypothyroidism	0.000878	0.00516	CcSEcCtD
Sumatriptan—Angina pectoris—Dextrothyroxine—hypothyroidism	0.000878	0.00516	CcSEcCtD
Sumatriptan—Swelling—Liotrix—hypothyroidism	0.00087	0.00511	CcSEcCtD
Sumatriptan—HTR1B—cardiovascular system—hypothyroidism	0.000851	0.031	CbGeAlD
Sumatriptan—Renal failure acute—Liotrix—hypothyroidism	0.000831	0.00488	CcSEcCtD
Sumatriptan—Body temperature increased—Liothyronine—hypothyroidism	0.000825	0.00485	CcSEcCtD
Sumatriptan—HTR1D—cardiovascular system—hypothyroidism	0.000824	0.03	CbGeAlD
Sumatriptan—Weight decreased—Dextrothyroxine—hypothyroidism	0.000816	0.00479	CcSEcCtD
Sumatriptan—Weight decreased—Levothyroxine—hypothyroidism	0.000816	0.00479	CcSEcCtD
Sumatriptan—HTR3A—blood—hypothyroidism	0.000802	0.0292	CbGeAlD
Sumatriptan—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.000793	0.00466	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.000793	0.00466	CcSEcCtD
Sumatriptan—Myocardial infarction—Levothyroxine—hypothyroidism	0.000788	0.00463	CcSEcCtD
Sumatriptan—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.000788	0.00463	CcSEcCtD
Sumatriptan—Hypoglycaemia—Liotrix—hypothyroidism	0.000786	0.00462	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Liotrix—hypothyroidism	0.000783	0.0046	CcSEcCtD
Sumatriptan—SLCO1B1—blood—hypothyroidism	0.000778	0.0283	CbGeAlD
Sumatriptan—Sweating—Dextrothyroxine—hypothyroidism	0.000771	0.00453	CcSEcCtD
Sumatriptan—Sweating—Levothyroxine—hypothyroidism	0.000771	0.00453	CcSEcCtD
Sumatriptan—Dehydration—Liotrix—hypothyroidism	0.000714	0.00419	CcSEcCtD
Sumatriptan—MAOA—adrenal cortex—hypothyroidism	0.000688	0.025	CbGeAlD
Sumatriptan—HTR1A—cardiovascular system—hypothyroidism	0.000687	0.025	CbGeAlD
Sumatriptan—Flushing—Levothyroxine—hypothyroidism	0.00067	0.00394	CcSEcCtD
Sumatriptan—Flushing—Dextrothyroxine—hypothyroidism	0.00067	0.00394	CcSEcCtD
Sumatriptan—Abdominal distension—Liotrix—hypothyroidism	0.000668	0.00392	CcSEcCtD
Sumatriptan—MAOA—heart—hypothyroidism	0.000665	0.0242	CbGeAlD
Sumatriptan—Dysphagia—Liotrix—hypothyroidism	0.000663	0.0039	CcSEcCtD
Sumatriptan—Bronchospasm—Liotrix—hypothyroidism	0.000652	0.00383	CcSEcCtD
Sumatriptan—Angina pectoris—Liotrix—hypothyroidism	0.000646	0.0038	CcSEcCtD
Sumatriptan—Arrhythmia—Levothyroxine—hypothyroidism	0.000645	0.00379	CcSEcCtD
Sumatriptan—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000645	0.00379	CcSEcCtD
Sumatriptan—Bronchitis—Liotrix—hypothyroidism	0.000638	0.00375	CcSEcCtD
Sumatriptan—MAOA—cardiovascular system—hypothyroidism	0.000628	0.0229	CbGeAlD
Sumatriptan—SLCO1B1—liver—hypothyroidism	0.000609	0.0222	CbGeAlD
Sumatriptan—Weight decreased—Liotrix—hypothyroidism	0.0006	0.00353	CcSEcCtD
Sumatriptan—ABCG2—adrenal cortex—hypothyroidism	0.000596	0.0217	CbGeAlD
Sumatriptan—Tremor—Levothyroxine—hypothyroidism	0.000589	0.00346	CcSEcCtD
Sumatriptan—Tremor—Dextrothyroxine—hypothyroidism	0.000589	0.00346	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Liotrix—hypothyroidism	0.000583	0.00343	CcSEcCtD
Sumatriptan—Myocardial infarction—Liotrix—hypothyroidism	0.00058	0.00341	CcSEcCtD
Sumatriptan—Agitation—Levothyroxine—hypothyroidism	0.000577	0.00339	CcSEcCtD
Sumatriptan—Agitation—Dextrothyroxine—hypothyroidism	0.000577	0.00339	CcSEcCtD
Sumatriptan—ABCG2—heart—hypothyroidism	0.000577	0.021	CbGeAlD
Sumatriptan—Angioedema—Dextrothyroxine—hypothyroidism	0.000574	0.00337	CcSEcCtD
Sumatriptan—Angioedema—Levothyroxine—hypothyroidism	0.000574	0.00337	CcSEcCtD
Sumatriptan—Sweating—Liotrix—hypothyroidism	0.000567	0.00333	CcSEcCtD
Sumatriptan—MAOA—pituitary gland—hypothyroidism	0.000556	0.0202	CbGeAlD
Sumatriptan—Palpitations—Levothyroxine—hypothyroidism	0.000555	0.00326	CcSEcCtD
Sumatriptan—Palpitations—Dextrothyroxine—hypothyroidism	0.000555	0.00326	CcSEcCtD
Sumatriptan—DRD2—pituitary gland—hypothyroidism	0.00055	0.02	CbGeAlD
Sumatriptan—Convulsion—Levothyroxine—hypothyroidism	0.000544	0.0032	CcSEcCtD
Sumatriptan—Convulsion—Dextrothyroxine—hypothyroidism	0.000544	0.0032	CcSEcCtD
Sumatriptan—HTR1A—adrenal gland—hypothyroidism	0.000543	0.0198	CbGeAlD
Sumatriptan—Arthralgia—Dextrothyroxine—hypothyroidism	0.000535	0.00314	CcSEcCtD
Sumatriptan—Arthralgia—Levothyroxine—hypothyroidism	0.000535	0.00314	CcSEcCtD
Sumatriptan—Anxiety—Dextrothyroxine—hypothyroidism	0.000533	0.00313	CcSEcCtD
Sumatriptan—Anxiety—Levothyroxine—hypothyroidism	0.000533	0.00313	CcSEcCtD
Sumatriptan—Hypoaesthesia—Liotrix—hypothyroidism	0.000528	0.0031	CcSEcCtD
Sumatriptan—SLCO1A2—testis—hypothyroidism	0.000524	0.0191	CbGeAlD
Sumatriptan—Confusional state—Dextrothyroxine—hypothyroidism	0.000517	0.00304	CcSEcCtD
Sumatriptan—Confusional state—Levothyroxine—hypothyroidism	0.000517	0.00304	CcSEcCtD
Sumatriptan—Shock—Dextrothyroxine—hypothyroidism	0.000504	0.00296	CcSEcCtD
Sumatriptan—Shock—Levothyroxine—hypothyroidism	0.000504	0.00296	CcSEcCtD
Sumatriptan—Tachycardia—Levothyroxine—hypothyroidism	0.0005	0.00294	CcSEcCtD
Sumatriptan—Tachycardia—Dextrothyroxine—hypothyroidism	0.0005	0.00294	CcSEcCtD
Sumatriptan—MAOA—adrenal gland—hypothyroidism	0.000496	0.0181	CbGeAlD
Sumatriptan—MAOA—blood—hypothyroidism	0.000496	0.0181	CbGeAlD
Sumatriptan—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000496	0.00291	CcSEcCtD
Sumatriptan—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000496	0.00291	CcSEcCtD
Sumatriptan—SLCO1A2—liver—hypothyroidism	0.000495	0.018	CbGeAlD
Sumatriptan—Flushing—Liotrix—hypothyroidism	0.000493	0.0029	CcSEcCtD
Sumatriptan—SLCO1A2—cerebellum—hypothyroidism	0.000484	0.0176	CbGeAlD
Sumatriptan—ABCG2—pituitary gland—hypothyroidism	0.000482	0.0175	CbGeAlD
Sumatriptan—MAOA—thyroid gland—hypothyroidism	0.000479	0.0174	CbGeAlD
Sumatriptan—Arrhythmia—Liotrix—hypothyroidism	0.000474	0.00279	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000467	0.00274	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000467	0.00274	CcSEcCtD
Sumatriptan—MAOA—female gonad—hypothyroidism	0.000463	0.0169	CbGeAlD
Sumatriptan—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000457	0.00269	CcSEcCtD
Sumatriptan—Dyspnoea—Levothyroxine—hypothyroidism	0.000457	0.00269	CcSEcCtD
Sumatriptan—Flatulence—Liotrix—hypothyroidism	0.000455	0.00268	CcSEcCtD
Sumatriptan—Dysgeusia—Liotrix—hypothyroidism	0.000453	0.00266	CcSEcCtD
Sumatriptan—Fatigue—Levothyroxine—hypothyroidism	0.000442	0.0026	CcSEcCtD
Sumatriptan—Fatigue—Dextrothyroxine—hypothyroidism	0.000442	0.0026	CcSEcCtD
Sumatriptan—Tremor—Liotrix—hypothyroidism	0.000433	0.00254	CcSEcCtD
Sumatriptan—ABCG2—adrenal gland—hypothyroidism	0.00043	0.0157	CbGeAlD
Sumatriptan—ABCG2—blood—hypothyroidism	0.00043	0.0157	CbGeAlD
Sumatriptan—Agitation—Liotrix—hypothyroidism	0.000425	0.0025	CcSEcCtD
Sumatriptan—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000423	0.00248	CcSEcCtD
Sumatriptan—Feeling abnormal—Levothyroxine—hypothyroidism	0.000423	0.00248	CcSEcCtD
Sumatriptan—Angioedema—Liotrix—hypothyroidism	0.000422	0.00248	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000419	0.00246	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000419	0.00246	CcSEcCtD
Sumatriptan—ABCG2—thyroid gland—hypothyroidism	0.000415	0.0151	CbGeAlD
Sumatriptan—HTR1A—cerebellum—hypothyroidism	0.000415	0.0151	CbGeAlD
Sumatriptan—Syncope—Liotrix—hypothyroidism	0.000414	0.00244	CcSEcCtD
Sumatriptan—MAOA—testis—hypothyroidism	0.00041	0.0149	CbGeAlD
Sumatriptan—Palpitations—Liotrix—hypothyroidism	0.000408	0.0024	CcSEcCtD
Sumatriptan—Urticaria—Levothyroxine—hypothyroidism	0.000407	0.00239	CcSEcCtD
Sumatriptan—Urticaria—Dextrothyroxine—hypothyroidism	0.000407	0.00239	CcSEcCtD
Sumatriptan—Loss of consciousness—Liotrix—hypothyroidism	0.000406	0.00239	CcSEcCtD
Sumatriptan—DRD2—testis—hypothyroidism	0.000406	0.0148	CbGeAlD
Sumatriptan—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000405	0.00238	CcSEcCtD
Sumatriptan—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000405	0.00238	CcSEcCtD
Sumatriptan—Abdominal pain—Levothyroxine—hypothyroidism	0.000405	0.00238	CcSEcCtD
Sumatriptan—Body temperature increased—Levothyroxine—hypothyroidism	0.000405	0.00238	CcSEcCtD
Sumatriptan—ABCG2—female gonad—hypothyroidism	0.000401	0.0146	CbGeAlD
Sumatriptan—Convulsion—Liotrix—hypothyroidism	0.0004	0.00235	CcSEcCtD
Sumatriptan—Hypertension—Liotrix—hypothyroidism	0.000399	0.00234	CcSEcCtD
Sumatriptan—Chest pain—Liotrix—hypothyroidism	0.000393	0.00231	CcSEcCtD
Sumatriptan—Arthralgia—Liotrix—hypothyroidism	0.000393	0.00231	CcSEcCtD
Sumatriptan—Anxiety—Liotrix—hypothyroidism	0.000392	0.0023	CcSEcCtD
Sumatriptan—MAOA—liver—hypothyroidism	0.000388	0.0141	CbGeAlD
Sumatriptan—Confusional state—Liotrix—hypothyroidism	0.00038	0.00223	CcSEcCtD
Sumatriptan—MAOA—cerebellum—hypothyroidism	0.000379	0.0138	CbGeAlD
Sumatriptan—Anaphylactic shock—Liotrix—hypothyroidism	0.000377	0.00222	CcSEcCtD
Sumatriptan—Oedema—Liotrix—hypothyroidism	0.000377	0.00222	CcSEcCtD
Sumatriptan—DRD2—cerebellum—hypothyroidism	0.000375	0.0137	CbGeAlD
Sumatriptan—Infection—Liotrix—hypothyroidism	0.000375	0.0022	CcSEcCtD
Sumatriptan—Shock—Liotrix—hypothyroidism	0.000371	0.00218	CcSEcCtD
Sumatriptan—Tachycardia—Liotrix—hypothyroidism	0.000368	0.00216	CcSEcCtD
Sumatriptan—Asthenia—Levothyroxine—hypothyroidism	0.000368	0.00216	CcSEcCtD
Sumatriptan—Asthenia—Dextrothyroxine—hypothyroidism	0.000368	0.00216	CcSEcCtD
Sumatriptan—Hyperhidrosis—Liotrix—hypothyroidism	0.000365	0.00214	CcSEcCtD
Sumatriptan—Pruritus—Dextrothyroxine—hypothyroidism	0.000363	0.00213	CcSEcCtD
Sumatriptan—Pruritus—Levothyroxine—hypothyroidism	0.000363	0.00213	CcSEcCtD
Sumatriptan—ABCG2—testis—hypothyroidism	0.000356	0.013	CbGeAlD
Sumatriptan—Hypotension—Liotrix—hypothyroidism	0.000352	0.00207	CcSEcCtD
Sumatriptan—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000351	0.00206	CcSEcCtD
Sumatriptan—Diarrhoea—Levothyroxine—hypothyroidism	0.000351	0.00206	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000344	0.00202	CcSEcCtD
Sumatriptan—Paraesthesia—Liotrix—hypothyroidism	0.000339	0.00199	CcSEcCtD
Sumatriptan—ABCG2—liver—hypothyroidism	0.000336	0.0123	CbGeAlD
Sumatriptan—Dyspnoea—Liotrix—hypothyroidism	0.000336	0.00198	CcSEcCtD
Sumatriptan—ABCG2—cerebellum—hypothyroidism	0.000329	0.012	CbGeAlD
Sumatriptan—Decreased appetite—Liotrix—hypothyroidism	0.000328	0.00193	CcSEcCtD
Sumatriptan—Vomiting—Levothyroxine—hypothyroidism	0.000326	0.00192	CcSEcCtD
Sumatriptan—Vomiting—Dextrothyroxine—hypothyroidism	0.000326	0.00192	CcSEcCtD
Sumatriptan—Fatigue—Liotrix—hypothyroidism	0.000325	0.00191	CcSEcCtD
Sumatriptan—Rash—Dextrothyroxine—hypothyroidism	0.000323	0.0019	CcSEcCtD
Sumatriptan—Rash—Levothyroxine—hypothyroidism	0.000323	0.0019	CcSEcCtD
Sumatriptan—Dermatitis—Levothyroxine—hypothyroidism	0.000323	0.0019	CcSEcCtD
Sumatriptan—Dermatitis—Dextrothyroxine—hypothyroidism	0.000323	0.0019	CcSEcCtD
Sumatriptan—Constipation—Liotrix—hypothyroidism	0.000323	0.0019	CcSEcCtD
Sumatriptan—Headache—Dextrothyroxine—hypothyroidism	0.000321	0.00189	CcSEcCtD
Sumatriptan—Headache—Levothyroxine—hypothyroidism	0.000321	0.00189	CcSEcCtD
Sumatriptan—Feeling abnormal—Liotrix—hypothyroidism	0.000311	0.00183	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Liotrix—hypothyroidism	0.000308	0.00181	CcSEcCtD
Sumatriptan—Nausea—Dextrothyroxine—hypothyroidism	0.000305	0.00179	CcSEcCtD
Sumatriptan—Nausea—Levothyroxine—hypothyroidism	0.000305	0.00179	CcSEcCtD
Sumatriptan—Urticaria—Liotrix—hypothyroidism	0.0003	0.00176	CcSEcCtD
Sumatriptan—Body temperature increased—Liotrix—hypothyroidism	0.000298	0.00175	CcSEcCtD
Sumatriptan—Abdominal pain—Liotrix—hypothyroidism	0.000298	0.00175	CcSEcCtD
Sumatriptan—ABCB1—adrenal cortex—hypothyroidism	0.000294	0.0107	CbGeAlD
Sumatriptan—ABCB1—heart—hypothyroidism	0.000284	0.0104	CbGeAlD
Sumatriptan—Hypersensitivity—Liotrix—hypothyroidism	0.000278	0.00163	CcSEcCtD
Sumatriptan—Asthenia—Liotrix—hypothyroidism	0.000271	0.00159	CcSEcCtD
Sumatriptan—ABCB1—cardiovascular system—hypothyroidism	0.000268	0.00977	CbGeAlD
Sumatriptan—Pruritus—Liotrix—hypothyroidism	0.000267	0.00157	CcSEcCtD
Sumatriptan—Diarrhoea—Liotrix—hypothyroidism	0.000258	0.00152	CcSEcCtD
Sumatriptan—Dizziness—Liotrix—hypothyroidism	0.000249	0.00147	CcSEcCtD
Sumatriptan—ABCB1—gonad—hypothyroidism	0.000243	0.00887	CbGeAlD
Sumatriptan—Vomiting—Liotrix—hypothyroidism	0.00024	0.00141	CcSEcCtD
Sumatriptan—Rash—Liotrix—hypothyroidism	0.000238	0.0014	CcSEcCtD
Sumatriptan—Dermatitis—Liotrix—hypothyroidism	0.000238	0.0014	CcSEcCtD
Sumatriptan—ABCB1—pituitary gland—hypothyroidism	0.000238	0.00865	CbGeAlD
Sumatriptan—Headache—Liotrix—hypothyroidism	0.000236	0.00139	CcSEcCtD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00023	0.0212	CbGpPWpGaD
Sumatriptan—Nausea—Liotrix—hypothyroidism	0.000224	0.00132	CcSEcCtD
Sumatriptan—ABCB1—adrenal gland—hypothyroidism	0.000212	0.00773	CbGeAlD
Sumatriptan—ABCB1—blood—hypothyroidism	0.000212	0.00773	CbGeAlD
Sumatriptan—ABCB1—thyroid gland—hypothyroidism	0.000205	0.00746	CbGeAlD
Sumatriptan—ABCB1—female gonad—hypothyroidism	0.000198	0.0072	CbGeAlD
Sumatriptan—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000197	0.0182	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000195	0.018	CbGpPWpGaD
Sumatriptan—ABCB1—testis—hypothyroidism	0.000175	0.00639	CbGeAlD
Sumatriptan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000168	0.0155	CbGpPWpGaD
Sumatriptan—ABCB1—liver—hypothyroidism	0.000166	0.00604	CbGeAlD
Sumatriptan—ABCB1—cerebellum—hypothyroidism	0.000162	0.0059	CbGeAlD
Sumatriptan—MAOA—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000154	0.0142	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000148	0.0137	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000134	0.0124	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000126	0.0116	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000124	0.0114	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—SLC5A7—hypothyroidism	0.000118	0.0108	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000115	0.0106	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000115	0.0106	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000115	0.0106	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000111	0.0103	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000103	0.00945	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000102	0.00941	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000102	0.00941	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—NEFL—hypothyroidism	9.9e-05	0.00912	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	9.52e-05	0.00878	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—NKX2-1—hypothyroidism	9.46e-05	0.00872	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—TRH—hypothyroidism	8.73e-05	0.00804	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—TSHB—hypothyroidism	7.78e-05	0.00717	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—TSHR—hypothyroidism	7.78e-05	0.00717	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—NEFL—hypothyroidism	7.58e-05	0.00699	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	7.33e-05	0.00675	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	7.18e-05	0.00661	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.83e-05	0.00629	CbGpPWpGaD
Sumatriptan—MAOA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.82e-05	0.00629	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	6.53e-05	0.00602	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	6.53e-05	0.00602	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	6.4e-05	0.00589	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	6.4e-05	0.00589	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.02e-05	0.00555	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—AVP—hypothyroidism	5.9e-05	0.00543	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	5.84e-05	0.00538	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.66e-05	0.00521	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—TRH—hypothyroidism	5.58e-05	0.00514	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	5.47e-05	0.00504	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—TRH—hypothyroidism	5.46e-05	0.00504	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	5.41e-05	0.00498	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.37e-05	0.00495	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—POMC—hypothyroidism	5.03e-05	0.00464	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—AVP—hypothyroidism	5.01e-05	0.00462	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—TSHB—hypothyroidism	4.97e-05	0.00458	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—TSHR—hypothyroidism	4.97e-05	0.00458	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.94e-05	0.00456	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—TRH—hypothyroidism	4.93e-05	0.00455	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	4.87e-05	0.00449	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	4.87e-05	0.00449	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—TSHR—hypothyroidism	4.87e-05	0.00449	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—TSHB—hypothyroidism	4.87e-05	0.00449	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.84e-05	0.00446	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	4.8e-05	0.00442	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—IYD—hypothyroidism	4.61e-05	0.00425	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	4.59e-05	0.00423	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—AVP—hypothyroidism	4.58e-05	0.00423	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.48e-05	0.00413	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—TRH—hypothyroidism	4.48e-05	0.00413	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—TSHB—hypothyroidism	4.4e-05	0.00405	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—TSHR—hypothyroidism	4.4e-05	0.00405	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	4.28e-05	0.00394	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	4.28e-05	0.00394	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—IYD—hypothyroidism	4.28e-05	0.00394	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.23e-05	0.0039	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—TRH—hypothyroidism	4.16e-05	0.00384	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4e-05	0.00369	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—TSHB—hypothyroidism	3.99e-05	0.00368	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—TSHR—hypothyroidism	3.99e-05	0.00368	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—IYD—hypothyroidism	3.95e-05	0.00364	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ATP5O—hypothyroidism	3.92e-05	0.00362	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—AVP—hypothyroidism	3.89e-05	0.00359	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	3.85e-05	0.00355	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	3.77e-05	0.00347	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—TSHB—hypothyroidism	3.71e-05	0.00342	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—TSHR—hypothyroidism	3.71e-05	0.00342	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TPO—hypothyroidism	3.69e-05	0.0034	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—TRH—hypothyroidism	3.65e-05	0.00337	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—IYD—hypothyroidism	3.65e-05	0.00337	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ATP5O—hypothyroidism	3.64e-05	0.00335	CbGpPWpGaD
Sumatriptan—MAOA—Biological oxidations—POMC—hypothyroidism	3.62e-05	0.00334	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	3.62e-05	0.00333	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—AVP—hypothyroidism	3.59e-05	0.00331	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TPO—hypothyroidism	3.42e-05	0.00315	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.42e-05	0.00315	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ATP5O—hypothyroidism	3.36e-05	0.00309	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—TSHR—hypothyroidism	3.26e-05	0.003	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—TSHB—hypothyroidism	3.26e-05	0.003	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—POMC—hypothyroidism	3.22e-05	0.00297	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TPO—hypothyroidism	3.15e-05	0.00291	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—TRH—hypothyroidism	3.15e-05	0.00291	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—POMC—hypothyroidism	3.15e-05	0.0029	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ATP5O—hypothyroidism	3.11e-05	0.00286	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—TRH—hypothyroidism	3.09e-05	0.00285	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CLTC—hypothyroidism	3.06e-05	0.00282	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—POMC—hypothyroidism	3.05e-05	0.00281	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—AVP—hypothyroidism	2.93e-05	0.0027	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	2.92e-05	0.00269	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.92e-05	0.00269	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TPO—hypothyroidism	2.92e-05	0.00269	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.87e-05	0.00265	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—AVP—hypothyroidism	2.87e-05	0.00265	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TRH—hypothyroidism	2.86e-05	0.00264	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—TSHB—hypothyroidism	2.81e-05	0.00259	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—TSHR—hypothyroidism	2.81e-05	0.00259	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TRH—hypothyroidism	2.8e-05	0.00258	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—TSHB—hypothyroidism	2.75e-05	0.00254	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—TSHR—hypothyroidism	2.75e-05	0.00254	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.73e-05	0.00252	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—VAV3—hypothyroidism	2.69e-05	0.00248	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TRH—hypothyroidism	2.65e-05	0.00244	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—AVP—hypothyroidism	2.59e-05	0.00239	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	2.56e-05	0.00236	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TSHB—hypothyroidism	2.55e-05	0.00235	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TSHR—hypothyroidism	2.55e-05	0.00235	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.52e-05	0.00232	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	2.51e-05	0.00231	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TSHB—hypothyroidism	2.5e-05	0.0023	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TSHR—hypothyroidism	2.5e-05	0.0023	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—VAV3—hypothyroidism	2.44e-05	0.00225	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.42e-05	0.00223	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—POMC—hypothyroidism	2.4e-05	0.00221	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TSHB—hypothyroidism	2.36e-05	0.00217	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TSHR—hypothyroidism	2.36e-05	0.00217	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AVP—hypothyroidism	2.35e-05	0.00217	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—TRH—hypothyroidism	2.35e-05	0.00217	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.33e-05	0.00215	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—AVP—hypothyroidism	2.19e-05	0.00202	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.16e-05	0.00199	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.15e-05	0.00198	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TRH—hypothyroidism	2.14e-05	0.00197	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	2.11e-05	0.00194	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SH2B3—hypothyroidism	2.1e-05	0.00194	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—TSHB—hypothyroidism	2.1e-05	0.00193	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—TSHR—hypothyroidism	2.1e-05	0.00193	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TRH—hypothyroidism	2.07e-05	0.0019	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—IYD—hypothyroidism	1.98e-05	0.00182	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CLTC—hypothyroidism	1.96e-05	0.0018	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—POMC—hypothyroidism	1.95e-05	0.0018	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—AVP—hypothyroidism	1.92e-05	0.00177	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CLTC—hypothyroidism	1.92e-05	0.00177	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.91e-05	0.00176	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—POMC—hypothyroidism	1.91e-05	0.00176	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TSHB—hypothyroidism	1.9e-05	0.00175	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TSHR—hypothyroidism	1.9e-05	0.00175	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TRH—hypothyroidism	1.88e-05	0.00173	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	1.84e-05	0.0017	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	1.84e-05	0.0017	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.84e-05	0.00169	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—POMC—hypothyroidism	1.72e-05	0.00159	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—VAV3—hypothyroidism	1.72e-05	0.00158	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TSHB—hypothyroidism	1.71e-05	0.00157	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	1.7e-05	0.00157	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TRH—hypothyroidism	1.69e-05	0.00156	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—VAV3—hypothyroidism	1.68e-05	0.00155	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ATP5O—hypothyroidism	1.68e-05	0.00155	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.68e-05	0.00154	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TSHR—hypothyroidism	1.67e-05	0.00154	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TSHB—hypothyroidism	1.67e-05	0.00154	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AVP—hypothyroidism	1.66e-05	0.00153	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TRH—hypothyroidism	1.66e-05	0.00153	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AVP—hypothyroidism	1.62e-05	0.0015	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TSHB—hypothyroidism	1.58e-05	0.00146	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TPO—hypothyroidism	1.58e-05	0.00146	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—POMC—hypothyroidism	1.56e-05	0.00144	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—VAV3—hypothyroidism	1.56e-05	0.00144	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PRL—hypothyroidism	1.56e-05	0.00144	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—VAV3—hypothyroidism	1.53e-05	0.00141	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3C2A—hypothyroidism	1.52e-05	0.0014	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSHR—hypothyroidism	1.51e-05	0.00139	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSHB—hypothyroidism	1.51e-05	0.00139	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AVP—hypothyroidism	1.5e-05	0.00139	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.5e-05	0.00138	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	1.48e-05	0.00136	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSHR—hypothyroidism	1.48e-05	0.00136	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSHB—hypothyroidism	1.48e-05	0.00136	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AVP—hypothyroidism	1.47e-05	0.00136	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.46e-05	0.00135	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CLTC—hypothyroidism	1.46e-05	0.00135	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—POMC—hypothyroidism	1.45e-05	0.00134	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VAV3—hypothyroidism	1.44e-05	0.00133	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3C2A—hypothyroidism	1.41e-05	0.0013	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AVP—hypothyroidism	1.39e-05	0.00128	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TSHB—hypothyroidism	1.35e-05	0.00125	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	1.34e-05	0.00124	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	1.32e-05	0.00121	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.3e-05	0.0012	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.28e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	1.28e-05	0.00118	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CLTC—hypothyroidism	1.28e-05	0.00118	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SLC5A5—hypothyroidism	1.28e-05	0.00118	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—POMC—hypothyroidism	1.28e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TRH—hypothyroidism	1.26e-05	0.00116	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	1.24e-05	0.00114	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3C2A—hypothyroidism	1.21e-05	0.00111	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SLC5A5—hypothyroidism	1.18e-05	0.00109	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.17e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	1.16e-05	0.00107	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	1.13e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSHB—hypothyroidism	1.12e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSHR—hypothyroidism	1.12e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AVP—hypothyroidism	1.12e-05	0.00103	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TRH—hypothyroidism	1.11e-05	0.00102	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	1.1e-05	0.00101	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.09e-05	0.00101	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AVP—hypothyroidism	1.09e-05	0.001	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	1.08e-05	0.000994	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—VAV3—hypothyroidism	1.02e-05	0.000943	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SLC5A5—hypothyroidism	1.01e-05	0.000933	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	1e-05	0.000924	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—POMC—hypothyroidism	1e-05	0.000921	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRL—hypothyroidism	9.97e-06	0.000919	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSHB—hypothyroidism	9.88e-06	0.00091	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSHR—hypothyroidism	9.88e-06	0.00091	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AVP—hypothyroidism	9.85e-06	0.000908	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—POMC—hypothyroidism	9.79e-06	0.000902	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRL—hypothyroidism	9.76e-06	0.0009	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—POMC—hypothyroidism	9.24e-06	0.000851	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VAV3—hypothyroidism	9.22e-06	0.00085	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	9.2e-06	0.000848	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VAV3—hypothyroidism	9.03e-06	0.000832	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AVP—hypothyroidism	8.89e-06	0.000819	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1—hypothyroidism	8.88e-06	0.000819	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SH2B3—hypothyroidism	8.8e-06	0.000811	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AVP—hypothyroidism	8.7e-06	0.000802	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	8.21e-06	0.000757	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—POMC—hypothyroidism	7.46e-06	0.000687	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRL—hypothyroidism	7.44e-06	0.000685	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TSHB—hypothyroidism	7.31e-06	0.000674	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—POMC—hypothyroidism	7.21e-06	0.000665	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VAV3—hypothyroidism	6.88e-06	0.000634	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—POMC—hypothyroidism	6.69e-06	0.000616	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AVP—hypothyroidism	6.63e-06	0.000611	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—POMC—hypothyroidism	6.55e-06	0.000603	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRL—hypothyroidism	6.53e-06	0.000602	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3C2A—hypothyroidism	6.52e-06	0.000601	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—hypothyroidism	6.2e-06	0.000571	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VAV3—hypothyroidism	6.04e-06	0.000557	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—hypothyroidism	5.91e-06	0.000544	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AVP—hypothyroidism	5.82e-06	0.000536	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—hypothyroidism	5.78e-06	0.000533	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—hypothyroidism	5.72e-06	0.000527	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—hypothyroidism	5.68e-06	0.000524	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—hypothyroidism	5.56e-06	0.000513	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC5A5—hypothyroidism	5.47e-06	0.000504	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—hypothyroidism	5.3e-06	0.000488	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—hypothyroidism	4.41e-06	0.000406	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—hypothyroidism	4.24e-06	0.000391	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—hypothyroidism	3.87e-06	0.000356	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—hypothyroidism	3.72e-06	0.000343	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—hypothyroidism	2.86e-06	0.000264	CbGpPWpGaD
